<DOC>
	<DOCNO>NCT00192361</DOCNO>
	<brief_summary>To assess whether CAIV-T transmit vaccinated child unvaccinated contact day care set ; , estimate rate transmission .</brief_summary>
	<brief_title>Trial Safety , Transmissibility , Phenotypic Genotypic Stability Influenza Virus Vaccine , ( CAIV-T ) , Children Who Attend Day Care . ( Final Report Version 2.0 )</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<criteria>least 8 month le 36 month age ( reach 3rd birthday ) time enrollment , good health determine medical history , physical examination , clinical judgment ; whose parent legal guardian provide write informed consent nature study explain ; , along parent legal guardian , available duration study ( 42 day postvaccination first study dose 42 day postvaccination supplemental dose CAIVT ) ; whose parent/legal guardian could reach telephone study staff postimmunization contact ; attend day care least three day per week four hour per day ; one least 4 child contact group/playroom ( least 4 child group require randomize study ) . whose parent legal guardian perceive unreliable unavailable evaluation study visit study period ; serious chronic disease ( e.g. , sign cardiac renal failure severe malnutrition ) , include progressive neurological disease asthma ; Down 's syndrome know cytogenetic disorder ; know suspected disease immune system receive immunosuppressive therapy , include systemic corticosteroid ; receive blood product , include immunoglobulin , period six month prior vaccination conclusion study ; intent administer investigational vaccine agent one month prior enrollment conclusion study ; immunosuppressed compromise individual playroom living household ; , time prior entry study , receive dose influenza vaccine ( commercial investigational ) ; document history hypersensitivity egg egg protein ; respiratory illness wheeze within two week prior enrollment ; receive aspirin ( acetylsalicylic acid ) aspirincontaining product two week prior enrollment use anticipate study ; administer live virus vaccine within one month prior enrollment expect receipt another live virus vaccine within one month vaccination study ; administer inactivated vaccine within two week prior enrollment expect receipt another inactivated vaccine within three week vaccination study ; medical condition opinion investigator might interfere interpretation study result .</criteria>
	<gender>All</gender>
	<minimum_age>8 Months</minimum_age>
	<maximum_age>36 Months</maximum_age>
	<verification_date>October 2006</verification_date>
</DOC>